A Review Of MOUNJARO INJECTION 5 mg
The trial accomplished the two its Main endpoints, with semaglutide 2.4 mg demonstrating statistically substantial and top-quality improvements in liver fibrosis without any worsening of steatohepatitis, and also resolution of steatohepatitis without having worsening of liver fibrosis in those with MASH compared to placebo.1Mumsnet hasn't checked t